High Susanna Gatti (CIK 0001691005)

Latest company ownership

Shares held
131,636
Last filed at
Sep 19, 2024
Confidence Score
50.0
2025Q4
Confidence Score History
2021Q3 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Sep 18, 2024 Sep 19, 2024 Dyne Therapeutics, Inc. COO Sell 30.0 -8,976 -6.38% $308.9K
Sep 11, 2024 Sep 11, 2024 Dyne Therapeutics, Inc. COO Sell 37.5 -5,270 -3.61% $168.1K
Aug 19, 2024 Aug 20, 2024 Dyne Therapeutics, Inc. COO Sell 45.0 -2,910 -1.96% $131.3K
Jun 21, 2024 Jul 3, 2024 Dyne Therapeutics, Inc. COO Sell 20.0 -40,000 -11.85% $1.4M
Jun 21, 2024 Jun 24, 2024 Dyne Therapeutics, Inc. COO Sell 20.0 -39,950 -11.84% $1.4M
Jun 12, 2024 Jun 13, 2024 Dyne Therapeutics, Inc. COO Sell 10.0 -40,000 -21.19% $1.3M
Jun 10, 2024 Jun 11, 2024 Dyne Therapeutics, Inc. COO Sell 5.0 -85,270 -36.43% $2.6M
May 16, 2024 May 17, 2024 Dyne Therapeutics, Inc. COO Sell 45.0 -2,738 -1.75% $77.4K
Mar 8, 2024 Mar 13, 2024 Dyne Therapeutics, Inc. COO Sell 17.5 -29,491 -15.83% $784.2K
Mar 7, 2024 Mar 11, 2024 Dyne Therapeutics, Inc. COO Sell 51.3 -1,591 -0.85% $41.1K
Dec 11, 2023 Dec 12, 2023 Dyne Therapeutics, Inc. COO Sell 51.3 -1,616 -0.85% $17.3K
Nov 2, 2023 Nov 2, 2023 Dyne Therapeutics, Inc. COO Sell 28.8 -9,939 -9.51% $73.5K
Sep 18, 2023 Sep 20, 2023 Dyne Therapeutics, Inc. COO Sell 45.0 -2,672 -2.49% $25.1K
Sep 12, 2023 Sep 13, 2023 Dyne Therapeutics, Inc. COO Sell 48.8 -1,635 -1.50% $17K
Jun 13, 2023 Jun 14, 2023 Dyne Therapeutics, Inc. COO Sell 48.8 -1,625 -1.47% $20.2K
Mar 14, 2023 Mar 15, 2023 Dyne Therapeutics, Inc. COO Sell 48.8 -1,559 -1.39% $20.8K
Dec 9, 2022 Dec 13, 2022 Dyne Therapeutics, Inc. COO Sell 90.0 +43,249 62.87% $8.2K
Sep 20, 2022 Sep 21, 2022 Dyne Therapeutics, Inc. COO Sell 41.3 -2,629 -3.68% $36K
Sep 15, 2022 Sep 15, 2022 Dyne Therapeutics, Inc. COO Sell 48.8 -786 -1.09% $11K
Jun 14, 2022 Jun 15, 2022 Dyne Therapeutics, Inc. COO Sell 50.0 -802 -1.10% $4K
Mar 11, 2022 Mar 14, 2022 Dyne Therapeutics, Inc. COO Sell 50.0 -765 -1.04% $6.7K
Sep 23, 2021 Sep 24, 2021 Dyne Therapeutics, Inc. COO Sell 36.3 -2,451 -6.83% $42.2K